申请人:DeVita J. Robert
公开号:US20070293492A1
公开(公告)日:2007-12-20
The present invention is directed to certain quinoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
本发明涉及某些喹啉化合物,其作为神经激肽-1(NK-1)受体拮抗剂和快速激肽,特别是物质P的抑制剂具有用途。本发明还涉及包含这些化合物作为活性成分的制药配方以及在治疗某些疾病,包括呕吐、尿失禁、抑郁症和焦虑症中使用这些化合物和它们的配方。